Alpha Cognition Inc. ACOG
7.80 USD -0.50 (-6.02%)
As ofNov 16, 2026, 1:27 PM EST
7.80 Day range 8.30
4.50 52-week range 10.14
- YTD
- +20.00%
- 1 year
- +31.31%
News
zacks.com Wall Street Analysts Predict an 119.28% Upside in Alpha Cognition Inc. (ACOG): Here's What You Should Know The consensus price target hints at an 119.3% upside potential for Alpha Cognition Inc. (ACOG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in…benzinga.com Alpha Cognition Announces Publication Of US Patent Application Covering Benzgalantamine For Treating Persistent Post-Concussion Symptoms Alpha Cognition Inc. (NASDAQ:ACOG) ("Alpha Cognition", "ACI", or the "Company"), a biopharmaceutical company developing and commercializing novel therapeutics for debilitating neurodegenerative
businesswire.com Alpha Cognition Announces Publication of U.S. Patent Application for Benzgalantamine for Treating Persistent Post-Concussion Symptoms VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing and commercializing novel…
seekingalpha.com Alpha Cognition Inc. (ACOG) Q3 2026 Earnings Call Transcript Alpha Cognition Inc. (ACOG) Q3 2026 Earnings Call Transcript
zacks.com Alpha Cognition Inc. (ACOG) Reports Q3 Loss, Beats Revenue Estimates Alpha Cognition Inc. (ACOG) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to a loss of $0.3 per share a year ago.
marketbeat.com What Alpha Cognition (ACOG) Said on Its Q3 Earnings Call Alpha Cognition NASDAQ: ACOG reported third-quarter 2026 net product revenue of approximately $7.8 million, up 30% from the preceding quarter, as prescriptions and prescriber adoption increased for…
benzinga.com Alpha Cognition Q3 2026 Earnings Call Transcript Alpha Cognition (NASDAQ:ACOG) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…benzinga.com Alpha Cognition Q3 EPS $(0.35) Misses $(0.34) Estimate, Sales $7.777M Beat $7.040M Estimate Alpha Cognition (NASDAQ:ACOG) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.34) by 6.06 percent. This is a 16.67 percent decrease over losses of…
businesswire.com Alpha Cognition Inc. Reports Third Quarter 2026 Financial Results and Provides Operational Update VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing and…
businesswire.com Alpha Cognition Strengthens Its Board of Directors with Appointment of Caren Deardorf VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company developing and commercializing novel…
